LAWSUITS NEWS & LEGAL INFORMATION
Search Results for
Sort by date 2,440 pages found matching data breach- Backdating of Stock Options under Federal Investigation
Jul-29-06 The U.S. Security and Exchange Commission (SEC) has announced that they will be investigating nearly 80 companies for stock option 'backdating' with nearly 40 companies facing criminal probes by the U.S. Justice Department. Federal officials held a [ press conference ] on July 21 in San Francisco to announce civil and criminal charges relating to allegati... - No Medicaid for Charité Artificial Spinal Disc
Jul-22-06 On May 16 2006, Centers for Medicare and Medicaid Services (CMS) denied Medicare coverage for Charité Artificial Spinal Discs in patients 60 years or older. The Wall Street Journal reported that there was a lack of evidence to indicate that surgery to implant the device was "reasonable and necessary", not to mention the cost: Charité comes with a pri... - Merck Not Losing Sleep Over Vioxx Disaster
Jul-16-06 Merck's top management team reportedly remains unphased by Vioxx litigation woes. In fact, Prudential Equity Group analyst, Timothy Anderson, says Merck's Chief Executive, Richard Clark, specifically told him that "Vioxx does not keep him up at night." According to Mr Anderson, "the company believes that lower court cases will be overturned on appeal, and... - Bush's Mental Illness Screening Squad On the Move
Jul-9-06 The tax dollar funded mental health screening programs popping up in every corner of the nation represent an enormous gift to Big Pharma from the Bush administration. After all, drug companies can't push drugs without a lucrative customer base, so the screening programs are a great solution for that little problem. On April 29, 2002, Bush kicked off th... - Pay-Per-Click advertising: E-Rip-Off?
Jun-30-06 Dave Johnson (not his real name) started using Yahoo's Overture about three years ago to advertise his spa equipment company and hopefully, draw traffic to his website. Everything ran smoothly for about six months but Johnson now likens his relationship with Overture as that of a drug addict - constantly needing a fix and paying out ever-increasing costs. ... - Add Triaminic Vapor Patch To List Of Dangerous Patches
Jun-25-06 On June 19, 2006, Novartis Consumer Health issued a recall for the cough-suppressing Triaminic Vapor Patches in the US, about three weeks after Health Canada issued a warning after a Canadian child who chewed on a patch suffered a seizure. There have been eight adverse events with the patch, all involving ingestion, Navartis spokesperson, Julie Masow, tol... - Understanding Class Action Settlement Administration
May-23-06 Understanding Class Action Settlement Administration In an effort to look for ways that will benefit our subscribers with new interests, www.lawyersandsettlements.com recently spoke with the president of an up-and-coming firm, Class Action Administration (CAA), Inc. CAA specializes in assisting attorneys with all phases of class action cases. CAA'... - Fosamax Does More Harm than Good
Apr-14-06 Dayton, OH The osteoporosis drug Fosamax has been on the market for a little over ten years now. Drug maker Merck promoted it heavily by selling women the fear of a disabling hip fracture and the necessity of regular bone-density tests. Merck's initial TV advertising campaign featured a slim woman in her mid-40s, conveying the notion that testing was app... - Sparlon: Just What Kids Need - Another ADHD Drug
Mar-20-06 The pharmaceutical company, Cephalon Inc, is going through the motions of legitimizing the sale of Sparlon for the treatment of ADHD even though its active ingredient, modafinil, has been heavily promoted and sold under the name Provigil, for off-label treatment of ADHD by Cephalon for years. Last October, the FDA sent an "approvable" letter to Cephalon f... - Trasylol Patients and Clinical Trial Subjects Beware
Mar-15-06 Thirteen years ago, the FDA approved Trasylol (aprotinin) for use in patients undergoing heart bypass surgery. In January 2006, doctors, consumer advocates and a medical research group called for the removal of the drug from the market after a study found it to have deadly side effects. Heart bypass surgery is performed to redirect blood around clogged ar... - Pfizer Makes List of Worst Corporate Evildoers
Mar-13-06 On January 3, 2006 the Global Exchange Report named the top fourteen "Worst Corporate Evildoers" in the world for 2005. Pfizer, one of the most profitable drug companies on earth, with sales over $52 billion in 2004, made the list of Evildoers. Pfizer's participation in the cover-up of the deadly side effects of Bextra surely contributed to its membership... - Reviewing ADHD Drugs - FDA Goes Through the Motions
Mar-12-06 Some of the top-selling drugs of all time are those prescribed to treat attention deficit disorders. Drug companies have physicians in every field of medicine pushing these medications and dole out millions of dollars worth of free samples each year to make sure they are passed out like candy. A new ADHD drug is set to come on the market that supposedly c... - Life After Depo-Medrol - Sheer Hopeless Hell
Mar-10-06 Complaining of a sudden localized hip pain, in January 2002, Dennis Capolongo, was diagnosed with a disc herniation and given 2 epidural injections of the steroid Depo-Medrol that resulted in two trips to the ER, a stint in the hospital, and horrific back pain that continued nonstop for months. A short time later, when reviewing his original MRIs, new doc... - Genentech and Biogen Legal Troubles - When It Rains It Pours
Mar-7-06 Rituxan gained FDA approval in 1997, as a treatment for a certain type of non-Hodgkin's lymphoma. Roughly 12,760 patients in the US have the form of cancer Rituxan was approved to treat. Yet by 2005, sales of the drug grew to $1.8 billion in the US. A lawsuit filed by a former Rituxan salesman explains how this happened. On January 11, 2006, Dow Jones r... - Tysabri Clinical Trial - Woman Misdiagnosed With MS Dies
Mar-1-06 It's always about money. Despite an annual cost of $23,500, initial sales of Tysabri were booming. As a once-a-month drug administered by a doctor, it received fast-track approval in late 2004. When it was withdrawn from the market 3 months later, 5,000 patients were on it and 15,000 more were awaiting insurance verification for the first dose. Biogen Ide... - Mirapex - Two Victims - Same Horror Story
Feb-16-06 In mid-2001, Joe Neglia went on a cruise to Alaska and that trip marked the beginning of his downward spiral into hell. The ship had a gambling casino on board and according to Joe, he was "instantly and savagely hooked on the slots." A major problem arose when he came back ashore. "When I returned from the cruise I began hitting the local casinos," he re... - Vaccinating For Profit - From Cradle to Coffin
Feb-2-06 Due to the flooding of special education classrooms, along with the rising medical costs of treating injured children, local taxes will soon go through the roof, at which time the public will be forced to face the unthinkable truth about the poisoned generation. And when that happens, government officials had better not even think about trying to feign i... - Silzone valves linked to Stroke and Adverse Side Effects
Jan-26-06 The St. Jude Silzone valve has now been withdrawn from the market but not before 36,000 Silzone coated heart valves had been implanted in patients throughout the world. Silver coating of the sewing ring (Silzone) was introduced as a modification of the St Jude Medical standard valve to provide antibacterial protection. The recall followed reports of u... - Drug Marketing Scheme Hits Nation's School System
Jan-26-06 TeenScreen, the elaborate drug marketing scheme concocted by the pharmaceutical industry and a front group operating out of Columbia University, is being promoted by the Bush administration's recommendation to screen the nation's school population for mental illness. The Bush appointed New Freedoms Commission on Mental Health issued a report in July 2003... - ADHD Medications could prove Deadly
Jan-5-06 A report was issued today by the FDA stating that cases of sudden death and serious side effects including hypertension, heart attack and stroke have been linked in association with therapeutic doses of drugs used to treat Attention Deficit Hyperactivity Disorder (ADHD) in both children and adults. The FDA Advisory Committee further says that "...